Your browser doesn't support javascript.
loading
Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study.
Rowan, C R; Keegan, D; Byrne, K; Cullen, G; Mulcahy, H E; Sheridan, J; Ryan, E J; de Vries, A; D'Haens, G; Doherty, G A.
Affiliation
  • Rowan CR; Center for Colorectal Disease, St. Vincent's University Hospital, School of Medicine, University College Dublin, Dublin, Ireland.
  • Keegan D; Center for Colorectal Disease, St. Vincent's University Hospital, School of Medicine, University College Dublin, Dublin, Ireland.
  • Byrne K; Center for Colorectal Disease, St. Vincent's University Hospital, School of Medicine, University College Dublin, Dublin, Ireland.
  • Cullen G; Center for Colorectal Disease, St. Vincent's University Hospital, School of Medicine, University College Dublin, Dublin, Ireland.
  • Mulcahy HE; Center for Colorectal Disease, St. Vincent's University Hospital, School of Medicine, University College Dublin, Dublin, Ireland.
  • Sheridan J; Center for Colorectal Disease, St. Vincent's University Hospital, School of Medicine, University College Dublin, Dublin, Ireland.
  • Ryan EJ; Center for Colorectal Disease, St. Vincent's University Hospital, School of Medicine, University College Dublin, Dublin, Ireland.
  • de Vries A; Sanquin Diagnostic Services, Amsterdam, The Netherlands.
  • D'Haens G; Department of Gastroenterology, Amsterdam Medical Centre, Amsterdam, The Netherlands.
  • Doherty GA; Center for Colorectal Disease, St. Vincent's University Hospital, School of Medicine, University College Dublin, Dublin, Ireland.
Aliment Pharmacol Ther ; 48(3): 333-339, 2018 08.
Article de En | MEDLINE | ID: mdl-29920697

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Crohn / Chimiothérapie d'induction / Ustékinumab Type d'étude: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male Langue: En Journal: Aliment Pharmacol Ther Sujet du journal: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Année: 2018 Type de document: Article Pays d'affiliation: Irlande Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Crohn / Chimiothérapie d'induction / Ustékinumab Type d'étude: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Adult / Female / Humans / Male Langue: En Journal: Aliment Pharmacol Ther Sujet du journal: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Année: 2018 Type de document: Article Pays d'affiliation: Irlande Pays de publication: Royaume-Uni